Northeast Kentucky Area Health Education Center’s Post

Empowerment through Education, Part V: Navigating Medical Cannabis Regulations In Part V of this multipart interview series, Jeremy Robbins and David Benedicktus, co-founders of Cannabis Patients Pacific Northwest (CPPNW), explain how physician perspective, the current scheduling of cannabis, and the differing state laws surrounding #medicalcannabis create challenges for accessing cannabis education and medicine. ➡️ Join us as we explore how patients navigate solutions to access their medicine: https://ow.ly/Laf950QuSEV

ICYMI: Below is the recording of a webinar we participated in last night. It was an engaging conversation about the patient experience in the UK with loads of really good questions at the end!

Such great conversations happening here. There's a lot of information AND misinformation about GLP-1 medications—check out this episode of Pharmland for some insights from industry experts!👇 #RxBenefits #Pharmland #Podcast

Click the link to read Dr Sarfaraz K. Niazi's new article about the FDA is taking an active role in identifying and counteracting misinformation about biosimilars and interchangeable biosimilar medications, resolving regulatory issues, and educating stakeholders, while addressing it is the stakeholders' responsibility to support the FDA's efforts....Stakeholders should promote better regulatory guidelines and work towards harmonizing them globally to allow for better amortization of the development cost. https://lnkd.in/eA9x66aB

🌱 Check out our new blog post authored by Berta Kaguako! 🌱 Gain insights into the world of Medical Cannabis (CBMPs) and its applications in treating psychological, neurological, and chronic pain conditions. Read more about eligibility criteria and safety measures here. https://lnkd.in/eC3fx-Zb #MedicalCannabis #CBMPs #HealthcareAwareness

Joins us for the latest hot topic!!

Next in our state series is South Carolina, where medical and adult use cannabis remains illegal. However, there are several SC senators who have been trying to get a medical cannabis bill passed by the House. ❤️🩹Republican Senator Tom Davis for instance has championed S. 423, or the Compassionate Care Act, a medical cannabis bill that would legalize cannabis use in oils, patches, salves, and vaporizers for specific illnesses. Approved illnesses include cancer, multiple sclerosis, glaucoma, sickle cell anemia, autism, Crohn’s disease, and neurological disorders such as epilepsy and PTSD. 🚭Smoking would remain illegal in SC. Additionally, the medical cannabis could only be obtained through a prescription and filled through specific pharmacies. Doctors would be required to have in-person visits with the patient who then could only obtain a two-week supply at a time. ✅While the SC Senate approved S. 423 in February 2024, the medical cannabis bill died in House when the session adjourned in May. Sen. Tom Davis hopes to reintroduce the bill in next year’s session. #freetheplant #southcarolinalaw #southcarolinacannabis #cannabislaw #cannabisdecriminalization #patientaccess #patientadvocacy

🌿 We are excited to have attended Cannabis Europa, where we connected with industry leaders to discuss advancements and the future of the medical cannabis market. Our platform continues to pave the way for secure, efficient global cannabis trade. Stay tuned for our key insights from the conference! -- Did not have the chance to discuss with us? Learn more here https://lnkd.in/gKiR6DZf #CannabisEuropa #CanXChange #CannabisIndustry #cannabisb2bmarketplace #cannabisindustry Sigfried Legeay Alex Arkentis Joe Seaman

Since 1992, FDA has paved the way for life-saving medicines to reach patients swiftly through the Accelerated Approval pathway, granted the drug demonstrates clinical benefit in a Phase IV confirmatory trial. In our new white paper, "RWE as Confirmatory Evidence for Accelerated Approvals," we delve into the transformative role of #RWE in helping drugs move through this process, including how it can help tackle challenges such as addressing surrogate endpoint validity. Download the white paper here: https://hubs.li/Q02tDTxV0

Since the law changed, only a handful of prescriptions for medical cannabis have been issued by the NHS. Patients unable to fund private prescriptions suffer due to the fear, stigma and financial barriers preventing them from accessing this safe, potentially life-changing, treatment. 📅Find out about how medical cannabis works or take part in a webinar or other event during #MCAW23. 💬By sharing your story – whether you are a medical cannabis patient or would like to explore this treatment- you can help raise awareness and reduce the associated stigma. 🤳You can tell your medical cannabis patient story by recording a video, audio clip or writing it down, anonymously if you wish. Then, share it. Add your story to social media and connect with fellow patients using #MCAW. 🌿Find out more: https://lnkd.in/e2vZpr2J